Indications for neoadjuvant radiation in esophageal adenocarcinoma: Times are changing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Indications for neoadjuvant radiation in esophageal adenocarcinoma: Times are changing

Published:2024-06 Issue: Volume:25 Page:201-203
ISSN:2666-2507
Container-title:JTCVS Techniques
language:en
Short-container-title:JTCVS Techniques

Author:

Worrell Stephanie G.

Publisher

Elsevier BV

Reference25 articles.

1. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group;Cooper;JAMA,1999

2. Accuracy of clinical staging and outcomes with primary resection for local-regionally limited esophageal adenocarcinoma;Worrell;Ann Surg,2018

3. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy and surgery compared with surgery alone for esophageal cancer: CALGB 9781;Tepper;J Clin Oncol,2008

4. Association between clinically staged node-negative esophageal adenocarcinoma and overall survival benefit from neoadjuvant chemoradiation;Gabriel;JAMA Surg,2016

5. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901;Mariette;J Clin Oncol,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3